Biodefense Market Surge Valuation Of USD 18.0 Billion By 2025: Grand View Research, Inc.
The
global biodefense market was valued at USD 9.68 billion
in 2015 and is expected to reach a value of USD 18.0 billion by 2025, according
to a new report by Grand View Research, Inc. The market is majorly governed by
the initiatives undertaken in the U.S. This country is the largest revenue
contributor and is anticipated to maintain its leading position throughout the
forecast period. Moreover, the funding received by manufacturers through
government-led biodefense projects, such as the BioShield initiative, is
expected to significantly contribute to vaccine development during the forecast
period.
The
growing initiatives undertaken by the private players, such as PharmAthene,
Inc.; Emergent BioSolutions, Inc.; and Ichor Medical Systems, are anticipated
to support market expansion. The technological advancements in the detection
systems, such as environmental detection (to treat biological target in the
environment) and CHIP-based detection, is further supporting the emergence of
this vertical.
Biodefense Market Revenue, By Product, 2014 - 2025 (USD Million) |
The
case of Ebola outbreak in 2014, especially in the U.S., west African countries,
and the west European countries is prompting regional government investments,
which is expected to boost the R&D efforts in developing countermeasures
against Ebola. The west European countries include Spain, Norway, Switzerland,
the Netherlands, Italy, Norway, Germany, France, and the UK.
Some
of the factors that are anticipated to propel sector growth during the forecast
period are stated below: -
- Based
on the analysis of the World Food Program, approximately 750,000 people
were anticipated to lose access to affordable food by the end of March
2015 due to the Ebola outbreak
- In the
2013 sarin gas and chemical attack, over 1,400 people died and
approximately 9,400 people were affected in Syria. During the period,
December 2012 to 2015, there were several victims identified to be harmed
by Sarin gas, mustard, chlorine, and other unconfirmed poisonous gases.
Browse full
research report on Biodefense Market: www.grandviewresearch.com/industry-analysis/biodefense-market
Further key
findings from the study suggest:
- In 2015, anthrax was the largest application
with a share of around 31.3%. The increasing government funding for the
construction of technologically advanced centers and the advent of various
technologies, such as gene chips, database management systems, and
nanotechnology, is expected to spur demand.
- Others segment, which includes agents that
cause glanders, tularemia, Ebola, and many more, are anticipated to grow
at a significant rate. The growing prevalence of viral hemorrhagic fevers
causing varied illnesses and the development of interventional products
against these conditions are expected to propel the demand.
- In 2015, North America held the majority
revenue share of over 89.9%. The government initiatives promoting the
biodefense sector with funding is a major factor impelling growth in this
space.
- Asia Pacific is anticipated to be the fastest
growing region. The presence of unmet demand for anti-cancer treatments,
rapidly expanding pharmaceutical industry, and growing investment in
countries, such as China, Japan, and India, for biodefense are expected to
support the emergence of this market in the coming years.
- Some of the key players are Xoma Corporation,
PharmAthene, Emergent Biosolutions, Dynavax Technologies Inc., SIGA
Technologies, Elusys Therapeutics, Ichor Medical Systems Inc., DynPort
Vaccine Company LLC, Cleveland BioLabs, Inc., Bavarian Nordic, Achaogen,
Nanotherapeutics, Inc., and Alnylam Pharmaceuticals.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the biodefense market by application
and region:
Global
Product outlook (Revenue in USD Million, 2014 - 2025)
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
Defense
- Others
Regional
outlook (Revenue in USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-biodefense-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment